The University of Hong Kong has pioneered a first-of-its-kind clinical trial that integrates lipofilling surgical practices with breast conservation, providing a new solution for cancer patients that promises to improve thei

📰

Continue Reading on South China Morning Post

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →